Bio-Techne Corporation (TECH)
Sells reagents and instruments that help researchers and doctors study proteins, diagnose diseases, and develop therapies.
$71.81+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+30.9%
The outlook
TECH is trading near the top of its 52-week range and above both major moving averages, signaling a strong recent uptrend. Analyst sentiment leans toward "hold," with an average price target sitting about 3% below the current price, suggesting caution despite the bullish technical positioning. The elevated trailing P/E of 102.6 reflects a premium valuation.
What’s behind the score
Analyst consensusHold — 2.7 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Price targetAvg target -3% vs current price
Analyst price target
~12-month · 12 analysts$70.00average target-2.5% vs now
Now $71.81
Low $50.00High $73.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$11.19B
52-wk high
$72.16
52-wk low
$43.20
50-day avg
$60.14
200-day avg
$59.38
Trailing P/E
102.6